Avenant Technologies 寻求林业发展局批准AI视力工具,以检测糖尿病眼病。 Avant Technologies seeks FDA approval for AI vision tool to detect diabetic eye disease.

AI正在通过智能剂、诊断和药物发现等应用来改变保健。 AI is transforming healthcare through applications like intelligent agents, diagnostics, and drug discovery. Avant Technology和Tempus AI公司等公司正在带头进行这项收费。 Companies such as Avant Technologies and Tempus AI are leading this charge. 预计到2034年AI诊断市场将达到465.9亿美元。 The AI diagnostics market is projected to hit $46.59 billion by 2034. 艾万特科技公司将于7月7日与FDA会面,寻求其Vision AI平台的批准,这是一种使用视网膜成像检测糖尿病视网膜病变的疾病查工具. Avant Technologies is set to meet with the FDA on July 7 to seek approval for their Vision AI platform, a disease-screening tool that uses retinal imaging to detect diabetic retinopathy. 一些药店连锁店已经免费提供扫描服务。 Free scans are already being offered in several pharmacy chains.